APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cyanocobalamin Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Cyanocobalamin Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025191 pages

Choose your research edition.

Industry ResearchCyanocobalamin Injection Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Cyanocobalamin Injection Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Cyanocobalamin Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cyanocobalamin Injection Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Cyanocobalamin Injection Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Cyanocobalamin Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Cyanocobalamin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cyanocobalamin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cyanocobalamin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cyanocobalamin Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cyanocobalamin Injection include ANGELINI, Bayer HealthCare, Biological E, Bristol-Myers Squibb, CCEPCD, Endo International, Huaxin Pharmaceutical, Jamieson and Luitpold Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cyanocobalamin Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cyanocobalamin Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cyanocobalamin Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cyanocobalamin Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Cyanocobalamin Injection Segment by Company

ANGELINI

Bayer HealthCare

Biological E

Bristol-Myers Squibb

CCEPCD

Endo International

Huaxin Pharmaceutical

Jamieson

Luitpold Pharmaceuticals

Luitpold Pharmaceuticals (Daiichi Sankyo)

Sanofi-Aventis

Pfizer

Mylan

Merck

Teva (Actavis)

Cyanocobalamin Injection Segment by Type

Vitamins

Supplements

Cyanocobalamin Injection Segment by Application

Hospitals

Clinics

Others

Cyanocobalamin Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyanocobalamin Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cyanocobalamin Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyanocobalamin Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cyanocobalamin Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cyanocobalamin Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Cyanocobalamin Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Cyanocobalamin Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Cyanocobalamin Injection Industry Trends Table 2. Cyanocobalamin Injection Industry Drivers Table 3. Cyanocobalamin Injection Industry Opportunities and Challenges Table 4. Cyanocobalamin Injection Industry Restraints Table 5. Global Cyanocobalamin Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Cyanocobalamin Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Cyanocobalamin Injection Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Cyanocobalamin Injection Sales Market Share by Manufacturers Table 9. Global Cyanocobalamin Injection Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Cyanocobalamin Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Cyanocobalamin Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Cyanocobalamin Injection Manufacturers, Product Type & Application Table 13. Global Cyanocobalamin Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Cyanocobalamin Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Vitamins Table 17. Major Manufacturers of Supplements Table 18. Global Cyanocobalamin Injection Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Cyanocobalamin Injection Sales by Type (2021-2026) & (K Units) Table 20. Global Cyanocobalamin Injection Sales by Type (2027-2032) & (K Units) Table 21. Global Cyanocobalamin Injection Sales Market Share by Type (2021-2026) Table 22. Global Cyanocobalamin Injection Sales Market Share by Type (2027-2032) Table 23. Global Cyanocobalamin Injection Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Cyanocobalamin Injection Revenue by Type (2021-2026) & (K Units) Table 25. Global Cyanocobalamin Injection Revenue by Type (2027-2032) & (K Units) Table 26. Global Cyanocobalamin Injection Revenue Market Share by Type (2021-2026) Table 27. Global Cyanocobalamin Injection Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospitals Table 29. Major Manufacturers of Clinics Table 30. Major Manufacturers of Others Table 31. Global Cyanocobalamin Injection Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Cyanocobalamin Injection Sales by Application (2021-2026) & (K Units) Table 33. Global Cyanocobalamin Injection Sales by Application (2027-2032) & (K Units) Table 34. Global Cyanocobalamin Injection Sales Market Share by Application (2021-2026) Table 35. Global Cyanocobalamin Injection Sales Market Share by Application (2027-2032) Table 36. Global Cyanocobalamin Injection Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Cyanocobalamin Injection Revenue by Application (2021-2026) & (K Units) Table 38. Global Cyanocobalamin Injection Revenue by Application (2027-2032) & (K Units) Table 39. Global Cyanocobalamin Injection Revenue Market Share by Application (2021-2026) Table 40. Global Cyanocobalamin Injection Revenue Market Share by Application (2027-2032) Table 41. Global Cyanocobalamin Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Cyanocobalamin Injection Sales by Region (2021-2026) & (K Units) Table 43. Global Cyanocobalamin Injection Sales Market Share by Region (2021-2026) Table 44. Global Cyanocobalamin Injection Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Cyanocobalamin Injection Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Cyanocobalamin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Cyanocobalamin Injection Sales by Country (2021-2026) & (K Units) Table 48. North America Cyanocobalamin Injection Sales by Country (2027-2032) & (K Units) Table 49. Europe Cyanocobalamin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Cyanocobalamin Injection Sales by Country (2021-2026) & (K Units) Table 51. Europe Cyanocobalamin Injection Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Cyanocobalamin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Cyanocobalamin Injection Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Cyanocobalamin Injection Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Cyanocobalamin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Cyanocobalamin Injection Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Cyanocobalamin Injection Sales by Country (2027-2032) & (K Units) Table 58. Global Cyanocobalamin Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Cyanocobalamin Injection Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Cyanocobalamin Injection Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Cyanocobalamin Injection Revenue Market Share by Region (2021-2026) Table 62. Global Cyanocobalamin Injection Revenue Market Share by Region (2027-2032) Table 63. ANGELINI Company Information Table 64. ANGELINI Business Overview Table 65. ANGELINI Cyanocobalamin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. ANGELINI Cyanocobalamin Injection Product Portfolio Table 67. ANGELINI Recent Development Table 68. Bayer HealthCare Company Information Table 69. Bayer HealthCare Business Overview Table 70. Bayer HealthCare Cyanocobalamin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Bayer HealthCare Cyanocobalamin Injection Product Portfolio Table 72. Bayer HealthCare Recent Development Table 73. Biological E Company Information Table 74. Biological E Business Overview Table 75. Biological E Cyanocobalamin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Biological E Cyanocobalamin Injection Product Portfolio Table 77. Biological E Recent Development Table 78. Bristol-Myers Squibb Company Information Table 79. Bristol-Myers Squibb Business Overview Table 80. Bristol-Myers Squibb Cyanocobalamin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Bristol-Myers Squibb Cyanocobalamin Injection Product Portfolio Table 82. Bristol-Myers Squibb Recent Development Table 83. CCEPCD Company Information Table 84. CCEPCD Business Overview Table 85. CCEPCD Cyanocobalamin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. CCEPCD Cyanocobalamin Injection Product Portfolio Table 87. CCEPCD Recent Development Table 88. Endo International Company Information Table 89. Endo International Business Overview Table 90. Endo International Cyanocobalamin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Endo International Cyanocobalamin Injection Product Portfolio Table 92. Endo International Recent Development Table 93. Huaxin Pharmaceutical Company Information Table 94. Huaxin Pharmaceutical Business Overview Table 95. Huaxin Pharmaceutical Cyanocobalamin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Huaxin Pharmaceutical Cyanocobalamin Injection Product Portfolio Table 97. Huaxin Pharmaceutical Recent Development Table 98. Jamieson Company Information Table 99. Jamieson Business Overview Table 100. Jamieson Cyanocobalamin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Jamieson Cyanocobalamin Injection Product Portfolio Table 102. Jamieson Recent Development Table 103. Luitpold Pharmaceuticals Company Information Table 104. Luitpold Pharmaceuticals Business Overview Table 105. Luitpold Pharmaceuticals Cyanocobalamin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Luitpold Pharmaceuticals Cyanocobalamin Injection Product Portfolio Table 107. Luitpold Pharmaceuticals Recent Development Table 108. Luitpold Pharmaceuticals (Daiichi Sankyo) Company Information Table 109. Luitpold Pharmaceuticals (Daiichi Sankyo) Business Overview Table 110. Luitpold Pharmaceuticals (Daiichi Sankyo) Cyanocobalamin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Luitpold Pharmaceuticals (Daiichi Sankyo) Cyanocobalamin Injection Product Portfolio Table 112. Luitpold Pharmaceuticals (Daiichi Sankyo) Recent Development Table 113. Sanofi-Aventis Company Information Table 114. Sanofi-Aventis Business Overview Table 115. Sanofi-Aventis Cyanocobalamin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Sanofi-Aventis Cyanocobalamin Injection Product Portfolio Table 117. Sanofi-Aventis Recent Development Table 118. Pfizer Company Information Table 119. Pfizer Business Overview Table 120. Pfizer Cyanocobalamin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Pfizer Cyanocobalamin Injection Product Portfolio Table 122. Pfizer Recent Development Table 123. Mylan Company Information Table 124. Mylan Business Overview Table 125. Mylan Cyanocobalamin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Mylan Cyanocobalamin Injection Product Portfolio Table 127. Mylan Recent Development Table 128. Merck Company Information Table 129. Merck Business Overview Table 130. Merck Cyanocobalamin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Merck Cyanocobalamin Injection Product Portfolio Table 132. Merck Recent Development Table 133. Teva (Actavis) Company Information Table 134. Teva (Actavis) Business Overview Table 135. Teva (Actavis) Cyanocobalamin Injection Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Teva (Actavis) Cyanocobalamin Injection Product Portfolio Table 137. Teva (Actavis) Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Cyanocobalamin Injection Distributors List Table 141. Cyanocobalamin Injection Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Cyanocobalamin Injection Product Image Figure 2. Global Cyanocobalamin Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cyanocobalamin Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Cyanocobalamin Injection Sales (2021-2032) & (K Units) Figure 5. Global Cyanocobalamin Injection Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Cyanocobalamin Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Vitamins Image Figure 9. Supplements Image Figure 10. Global Cyanocobalamin Injection Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Cyanocobalamin Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Cyanocobalamin Injection Sales Market Share by Type (2021-2032) Figure 13. Global Cyanocobalamin Injection Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Cyanocobalamin Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Cyanocobalamin Injection Revenue Market Share by Type (2021-2032) Figure 16. Hospitals Image Figure 17. Clinics Image Figure 18. Others Image Figure 19. Global Cyanocobalamin Injection Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Cyanocobalamin Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Cyanocobalamin Injection Sales Market Share by Application (2021-2032) Figure 22. Global Cyanocobalamin Injection Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Cyanocobalamin Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Cyanocobalamin Injection Revenue Market Share by Application (2021-2032) Figure 25. North America Cyanocobalamin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Cyanocobalamin Injection Sales Market Share by Country (2021-2032) Figure 27. U.S. Cyanocobalamin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Cyanocobalamin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Cyanocobalamin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Cyanocobalamin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Cyanocobalamin Injection Sales Market Share by Country (2021-2032) Figure 32. Germany Cyanocobalamin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Cyanocobalamin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Cyanocobalamin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Cyanocobalamin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Cyanocobalamin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Cyanocobalamin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Cyanocobalamin Injection Sales Market Share by Country (2021-2032) Figure 39. China Cyanocobalamin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Cyanocobalamin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Cyanocobalamin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Cyanocobalamin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Cyanocobalamin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Cyanocobalamin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Cyanocobalamin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Cyanocobalamin Injection Sales Market Share by Country (2021-2032) Figure 47. Brazil Cyanocobalamin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Cyanocobalamin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Cyanocobalamin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Cyanocobalamin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Cyanocobalamin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Cyanocobalamin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Cyanocobalamin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Cyanocobalamin Injection Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Cyanocobalamin Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Cyanocobalamin Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Cyanocobalamin Injection Revenue (2021-2032) & (US$ Million) Figure 58. North America Cyanocobalamin Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Cyanocobalamin Injection Revenue (2021-2032) & (US$ Million) Figure 60. Europe Cyanocobalamin Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Cyanocobalamin Injection Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Cyanocobalamin Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Cyanocobalamin Injection Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Cyanocobalamin Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Cyanocobalamin Injection Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Cyanocobalamin Injection Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Vitamins
  • Supplements
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • ANGELINI
  • Bayer HealthCare
  • Biological E
  • Bristol-Myers Squibb
  • CCEPCD
  • Endo International
  • Huaxin Pharmaceutical
  • Jamieson
  • Luitpold Pharmaceuticals
  • Luitpold Pharmaceuticals (Daiichi Sankyo)
  • Sanofi-Aventis
  • Pfizer
  • Mylan
  • Merck
  • Teva (Actavis)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cyanocobalamin Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cyanocobalamin Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Cyanocobalamin Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Cyanocobalamin Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Cyanocobalamin Injection Market Dynamics
  1. 2.1 Cyanocobalamin Injection Industry Trends
  2. 2.2 Cyanocobalamin Injection Industry Drivers
  3. 2.3 Cyanocobalamin Injection Industry Opportunities and Challenges
  4. 2.4 Cyanocobalamin Injection Industry Restraints
3 Cyanocobalamin Injection Market by Manufacturers
  1. 3.1 Global Cyanocobalamin Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Cyanocobalamin Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Cyanocobalamin Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Cyanocobalamin Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cyanocobalamin Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Cyanocobalamin Injection Manufacturers, Product Type & Application
  7. 3.7 Global Cyanocobalamin Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cyanocobalamin Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cyanocobalamin Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cyanocobalamin Injection Tier 1, Tier 2, and Tier 3
4 Cyanocobalamin Injection Market by Type
  1. 4.1 Cyanocobalamin Injection Type Introduction
  2. 4.1.1 Vitamins
  3. 4.1.2 Supplements
  4. 4.2 Global Cyanocobalamin Injection Sales by Type
  5. 4.2.1 Global Cyanocobalamin Injection Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Cyanocobalamin Injection Sales by Type (2021-2032)
  7. 4.2.3 Global Cyanocobalamin Injection Sales Market Share by Type (2021-2032)
  8. 4.3 Global Cyanocobalamin Injection Revenue by Type
  9. 4.3.1 Global Cyanocobalamin Injection Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Cyanocobalamin Injection Revenue by Type (2021-2032)
  11. 4.3.3 Global Cyanocobalamin Injection Revenue Market Share by Type (2021-2032)
5 Cyanocobalamin Injection Market by Application
  1. 5.1 Cyanocobalamin Injection Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Others
  5. 5.2 Global Cyanocobalamin Injection Sales by Application
  6. 5.2.1 Global Cyanocobalamin Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cyanocobalamin Injection Sales by Application (2021-2032)
  8. 5.2.3 Global Cyanocobalamin Injection Sales Market Share by Application (2021-2032)
  9. 5.3 Global Cyanocobalamin Injection Revenue by Application
  10. 5.3.1 Global Cyanocobalamin Injection Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Cyanocobalamin Injection Revenue by Application (2021-2032)
  12. 5.3.3 Global Cyanocobalamin Injection Revenue Market Share by Application (2021-2032)
6 Global Cyanocobalamin Injection Sales by Region
  1. 6.1 Global Cyanocobalamin Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cyanocobalamin Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Cyanocobalamin Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Cyanocobalamin Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cyanocobalamin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Cyanocobalamin Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Cyanocobalamin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Cyanocobalamin Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Cyanocobalamin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Cyanocobalamin Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Cyanocobalamin Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Cyanocobalamin Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Cyanocobalamin Injection Revenue by Region
  1. 7.1 Global Cyanocobalamin Injection Revenue by Region
  2. 7.1.1 Global Cyanocobalamin Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Cyanocobalamin Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Cyanocobalamin Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Cyanocobalamin Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Cyanocobalamin Injection Revenue (2021-2032)
  8. 7.2.2 North America Cyanocobalamin Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Cyanocobalamin Injection Revenue (2021-2032)
  11. 7.3.2 Europe Cyanocobalamin Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Cyanocobalamin Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Cyanocobalamin Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Cyanocobalamin Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Cyanocobalamin Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 ANGELINI
  2. 8.1.1 ANGELINI Company Information
  3. 8.1.2 ANGELINI Business Overview
  4. 8.1.3 ANGELINI Cyanocobalamin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 ANGELINI Cyanocobalamin Injection Product Portfolio
  6. 8.1.5 ANGELINI Recent Developments
  7. 8.2 Bayer HealthCare
  8. 8.2.1 Bayer HealthCare Company Information
  9. 8.2.2 Bayer HealthCare Business Overview
  10. 8.2.3 Bayer HealthCare Cyanocobalamin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Bayer HealthCare Cyanocobalamin Injection Product Portfolio
  12. 8.2.5 Bayer HealthCare Recent Developments
  13. 8.3 Biological E
  14. 8.3.1 Biological E Company Information
  15. 8.3.2 Biological E Business Overview
  16. 8.3.3 Biological E Cyanocobalamin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Biological E Cyanocobalamin Injection Product Portfolio
  18. 8.3.5 Biological E Recent Developments
  19. 8.4 Bristol-Myers Squibb
  20. 8.4.1 Bristol-Myers Squibb Company Information
  21. 8.4.2 Bristol-Myers Squibb Business Overview
  22. 8.4.3 Bristol-Myers Squibb Cyanocobalamin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bristol-Myers Squibb Cyanocobalamin Injection Product Portfolio
  24. 8.4.5 Bristol-Myers Squibb Recent Developments
  25. 8.5 CCEPCD
  26. 8.5.1 CCEPCD Company Information
  27. 8.5.2 CCEPCD Business Overview
  28. 8.5.3 CCEPCD Cyanocobalamin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 CCEPCD Cyanocobalamin Injection Product Portfolio
  30. 8.5.5 CCEPCD Recent Developments
  31. 8.6 Endo International
  32. 8.6.1 Endo International Company Information
  33. 8.6.2 Endo International Business Overview
  34. 8.6.3 Endo International Cyanocobalamin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Endo International Cyanocobalamin Injection Product Portfolio
  36. 8.6.5 Endo International Recent Developments
  37. 8.7 Huaxin Pharmaceutical
  38. 8.7.1 Huaxin Pharmaceutical Company Information
  39. 8.7.2 Huaxin Pharmaceutical Business Overview
  40. 8.7.3 Huaxin Pharmaceutical Cyanocobalamin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Huaxin Pharmaceutical Cyanocobalamin Injection Product Portfolio
  42. 8.7.5 Huaxin Pharmaceutical Recent Developments
  43. 8.8 Jamieson
  44. 8.8.1 Jamieson Company Information
  45. 8.8.2 Jamieson Business Overview
  46. 8.8.3 Jamieson Cyanocobalamin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Jamieson Cyanocobalamin Injection Product Portfolio
  48. 8.8.5 Jamieson Recent Developments
  49. 8.9 Luitpold Pharmaceuticals
  50. 8.9.1 Luitpold Pharmaceuticals Company Information
  51. 8.9.2 Luitpold Pharmaceuticals Business Overview
  52. 8.9.3 Luitpold Pharmaceuticals Cyanocobalamin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Luitpold Pharmaceuticals Cyanocobalamin Injection Product Portfolio
  54. 8.9.5 Luitpold Pharmaceuticals Recent Developments
  55. 8.10 Luitpold Pharmaceuticals (Daiichi Sankyo)
  56. 8.10.1 Luitpold Pharmaceuticals (Daiichi Sankyo) Company Information
  57. 8.10.2 Luitpold Pharmaceuticals (Daiichi Sankyo) Business Overview
  58. 8.10.3 Luitpold Pharmaceuticals (Daiichi Sankyo) Cyanocobalamin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Luitpold Pharmaceuticals (Daiichi Sankyo) Cyanocobalamin Injection Product Portfolio
  60. 8.10.5 Luitpold Pharmaceuticals (Daiichi Sankyo) Recent Developments
  61. 8.11 Sanofi-Aventis
  62. 8.11.1 Sanofi-Aventis Company Information
  63. 8.11.2 Sanofi-Aventis Business Overview
  64. 8.11.3 Sanofi-Aventis Cyanocobalamin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sanofi-Aventis Cyanocobalamin Injection Product Portfolio
  66. 8.11.5 Sanofi-Aventis Recent Developments
  67. 8.12 Pfizer
  68. 8.12.1 Pfizer Company Information
  69. 8.12.2 Pfizer Business Overview
  70. 8.12.3 Pfizer Cyanocobalamin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Pfizer Cyanocobalamin Injection Product Portfolio
  72. 8.12.5 Pfizer Recent Developments
  73. 8.13 Mylan
  74. 8.13.1 Mylan Company Information
  75. 8.13.2 Mylan Business Overview
  76. 8.13.3 Mylan Cyanocobalamin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Mylan Cyanocobalamin Injection Product Portfolio
  78. 8.13.5 Mylan Recent Developments
  79. 8.14 Merck
  80. 8.14.1 Merck Company Information
  81. 8.14.2 Merck Business Overview
  82. 8.14.3 Merck Cyanocobalamin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Merck Cyanocobalamin Injection Product Portfolio
  84. 8.14.5 Merck Recent Developments
  85. 8.15 Teva (Actavis)
  86. 8.15.1 Teva (Actavis) Company Information
  87. 8.15.2 Teva (Actavis) Business Overview
  88. 8.15.3 Teva (Actavis) Cyanocobalamin Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Teva (Actavis) Cyanocobalamin Injection Product Portfolio
  90. 8.15.5 Teva (Actavis) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cyanocobalamin Injection Value Chain Analysis
  2. 9.1.1 Cyanocobalamin Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cyanocobalamin Injection Production Mode & Process
  6. 9.2 Cyanocobalamin Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cyanocobalamin Injection Distributors
  9. 9.2.3 Cyanocobalamin Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst